Literature DB >> 27904784

High FOXRED1 expression predicted good prognosis of colorectal cancer.

Weiqiang Fei1, Shuiping Liu1, Xiaotong Hu1.   

Abstract

The human FAD-dependent oxidoreductase domain containing 1 (FOXRED1) protein is reported as an assembly factor which promotes the correct assembly and stability of mitochondrial Complex I (CI). Alterations of mitochondrial CI might cause tumorigenesis and metastasis, but it's molecular mechanisms remain unclear. In this study, we selected 145 cases of colorectal cancer for immunohistochemistry to explore the role of FOXRED1 played in the tumor progression of colorectal cancer. The relationship between FOXRED1 expression and clinicopathological features of colorectal cancers was evaluated. FOXRED1 mainly localized in the cytoplasm in the colorectal cancer tissues, and had significant association with histopathological grading, depth of invasion, lymph node metastasis, distant metastasis and TNM stage (P<0.05 for each). However, age, gender and tumor location was not found to be associated with FOXRED1 expression. Colorectal cancer patients with higher expression of FOXRED1 had the higher 3 year survival rate (P=0.003). Moreover, FOXRED1 had potentiality to be an independent prognostic factor for survival in colorectal cancer (P=0.04). Low FOXRED1 expression correlated with poor prognosis of colorectal cancer and targeting this molecular will be a potential treatment strategy for colorectal cancer.

Entities:  

Keywords:  FOXRED1; colorectal cancer; immunohistochemistry; prognosis

Year:  2016        PMID: 27904784      PMCID: PMC5126286     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  23 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

2.  A structural model for FOXRED1, an FAD-dependent oxidoreductase necessary for NADH: Ubiquinone oxidoreductase (complex I) assembly.

Authors:  Bernard D Lemire
Journal:  Mitochondrion       Date:  2015-03-09       Impact factor: 4.160

3.  Anti-cancer analogues ME-143 and ME-344 exert toxicity by directly inhibiting mitochondrial NADH: ubiquinone oxidoreductase (Complex I).

Authors:  Sze Chern Lim; Kirstyn T Carey; Matthew McKenzie
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

4.  Evolution of FOXRED1, an FAD-dependent oxidoreductase necessary for NADH:ubiquinone oxidoreductase (Complex I) assembly.

Authors:  Bernard D Lemire
Journal:  Biochim Biophys Acta       Date:  2015-02-10

Review 5.  A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine.

Authors:  Douglas C Wallace
Journal:  Annu Rev Genet       Date:  2005       Impact factor: 16.830

6.  The dimensions of the CRC problem.

Authors:  L V Karsa; T A Lignini; J Patnick; R Lambert; C Sauvaget
Journal:  Best Pract Res Clin Gastroenterol       Date:  2010-08       Impact factor: 3.043

Review 7.  mTOR: from growth signal integration to cancer, diabetes and ageing.

Authors:  Roberto Zoncu; Alejo Efeyan; David M Sabatini
Journal:  Nat Rev Mol Cell Biol       Date:  2010-12-15       Impact factor: 94.444

8.  Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation.

Authors:  Lokendra Kumar Sharma; Hezhi Fang; Jiangtao Liu; Rasika Vartak; Janice Deng; Yidong Bai
Journal:  Hum Mol Genet       Date:  2011-09-02       Impact factor: 6.150

9.  High-throughput, pooled sequencing identifies mutations in NUBPL and FOXRED1 in human complex I deficiency.

Authors:  Sarah E Calvo; Elena J Tucker; Alison G Compton; Denise M Kirby; Gabriel Crawford; Noel P Burtt; Manuel Rivas; Candace Guiducci; Damien L Bruno; Olga A Goldberger; Michelle C Redman; Esko Wiltshire; Callum J Wilson; David Altshuler; Stacey B Gabriel; Mark J Daly; David R Thorburn; Vamsi K Mootha
Journal:  Nat Genet       Date:  2010-09-05       Impact factor: 38.330

Review 10.  Autophagy and metastasis: another double-edged sword.

Authors:  Candia M Kenific; Andrew Thorburn; Jayanta Debnath
Journal:  Curr Opin Cell Biol       Date:  2009-11-27       Impact factor: 8.382

View more
  1 in total

1.  Analysis of Prognostic Alternative Splicing Reveals the Landscape of Immune Microenvironment in Thyroid Cancer.

Authors:  Jian Wu; Yifang Sun; Junzheng Li; Maomao Ai; Lihua You; Jianbo Shi; Feng Yu
Journal:  Front Oncol       Date:  2021-10-18       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.